Home / Cabergoline / Australia
AU ATC N04BC06 · updated 2 Nov 2026
Cabergoline shortage in Australia
Is there a Cabergoline shortage in Australia?
Yes. As of 2 Nov 2026, 2 Cabergoline products are reported short in Australia, the first since 25 Jun 2026. The company estimate for the return is 6 Nov 2026. Main reason: not stated.
Also short in Germany, Spain. All countries.
Affected products in Australia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AU | CABASER Cabergoline 1mg tablet bottle | 25 Jun 2026 | 6 Nov 2026 | Not stated | |
| AU | CABASER Cabergoline 2mg tablet bottle limited | 25 Jun 2026 | 6 Nov 2026 | Not stated |
Source
Therapeutic Goods Administration (TGA), Medicine Shortage Reports Database. Official list. National shortages of reportable medicines, current and anticipated within six months; one row per product.